Pravin Bhansali

Pravin Bhansali

Auto-generated profile, based on publicly available information

Pravin Bhansali

Department of Chemistry, Faculty of Sciences and Technology Alliance University Bengaluru Karnataka India

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
SASalahuddin Ahmed
Salahuddin Ahmed
SRSharayah Riegsecker
Sharayah Riegsecker
MBMaria Beamer
Maria Beamer
ARAyesha Rahman
Ayesha Rahman
JBJoseph V. Bellini
Joseph V. Bellini
LTL.M. Viranga Tillekeratne
L.M. Viranga Tillekeratne

21 September 2011 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
PBPravin Bhansali
Pravin Bhansali
CHChristin L. Hanigan
Christin L. Hanigan
RJRobert A. Casero, Jr.
Robert A. Casero, Jr.
LTL. M. Viranga Tillekeratne
L. M. Viranga Tillekeratne

22 February 2022 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
YWYasanandana S. Wijayasinghe
Yasanandana S. Wijayasinghe
MBMeenakshi P. Bhansali
Meenakshi P. Bhansali
MBMaheshkumar R. Borkar
Maheshkumar R. Borkar
GCGanesh U. Chaturbhuj
Ganesh U. Chaturbhuj
BMBrian Muntean
Brian Muntean
PBPravin R. Bhansali
Pravin R. Bhansali

12 October 2021 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
YWYasanandana Supunsiri Wijayasinghe
Yasanandana Supunsiri Wijayasinghe
PBPravin Bhansali
Pravin Bhansali
RVRonald E. Viola
Ronald E. Viola
Mohammad KamalMohammad Kamal
Mohammad Kamal
NPNitesh Kumar Poddar
Nitesh Kumar Poddar
Today, the world is suffering from the pandemic of a novel coronavirus disease (COVID-19), a respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This pandemic is the third fatal coronavirus outbreak that has already occurred in the 21st century. Even six months after its emergence, hundreds of thousands of people are still being infected with SARS-CoV-2, and thousands of lives are lost every day across the world. No effective therapy has been approved to date for the treatment of this disease, suggesting the need to broaden the scope in the search for effective treatments. Throughout history, folk medicine has been successfully used to treat various ailments in humans, and Traditional Chinese Medicine has been instrumental in the containment of a number of viral diseases. Owing to their high chemical diversity and safety profiles, natural products offer great promises as potentially effective antiviral drugs. In recent years, a large number of anti-coronaviral phytochemicals with different mechanisms of action have been identified. Among them, tetra-O-galloyl-β-D-glucose, caffeic acid, and saikosaponin B2 block viral entry. A number of flavonoids inhibit viral proteases. Silvestrol inhibits protein synthesis. Myricetin and scutellarein inhibit viral replication. Emodin, luteolin, and quercetin demonstrate anti-coronaviral activity by inhibiting multiple processes in the virus life cycle. In this review, we critically evaluate the findings of the natural product-based anticoronaviral research that has been published during the last two decades, and attempt to provide a comprehensive description about their utility as potential broad-spectrum anti-coronaviral drugs, examining leads that may guide/facilitate anti-SARS-CoV-2 drug development studies.

1 October 2014 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
PBPravin Bhansali
Pravin Bhansali
CHChristin L. Hanigan
Christin L. Hanigan
Lalith PereraLalith Perera
Lalith Perera
RJRobert A. Casero, Jr.
Robert A. Casero, Jr.
LTL. M. Viranga Tillekeratne
L. M. Viranga Tillekeratne

1 August 2013 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
SZStephen P. Zano
Stephen P. Zano
PBPravin Bhansali
Pravin Bhansali
ALAmarjit Luniwal
Amarjit Luniwal
RVRonald E. Viola
Ronald E. Viola